India's Dr Reddy's get U.S. nod for blood pressure tablets
(Reuters) - U.S. health regulators approved Indian drugmaker Dr Reddy's Laboratories' application to market generic version of AstraZeneca Plc's blood-pressure medicine Toprol-XL.
Shares of the company were up 1.51 percent at 1,671 rupees as of 0712 GMT.
(Reporting by Kaustubh Kulkarni in Mumbai; Editing by Anand Basu)
- Tweet this
- Share this
- Digg this